Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Clarinex tablets to Zyrtec tablets in patients with seasonal and perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clarinex (desloratadine)
  • ZYRTEC (cetirizine hydrochloride)

Snippet

Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis | Phase 4 | Status: COMPLETED